Lopez-Guillermo A, Canales MA, Dlouhy I, Mercadal S, et al. A randomized phase II study comparing consolidation with a single dose of (90)Y ibritumomab tiuxetan vs. maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up results. Leuk Lymphoma 2021 Aug 30:1-8. doi: 10.1080/10428194.2021.1971216.
PMID: 34459702